Measures of dyspnea in pulmonary rehabilitation

Ernesto Crisafulli, Enrico M Clini, Ernesto Crisafulli, Enrico M Clini

Abstract

Dyspnea is the main symptom perceived by patients affected by chronic respiratory diseases. It derives from a complex interaction of signals arising in the central nervous system, which is connected through afferent pathway receptors to the peripheral respiratory system (airways, lung, and thorax). Notwithstanding the mechanism that generates the stimulus is always the same, the sensation of dyspnea is often described with different verbal descriptors: these descriptors, or linguistic 'clusters', are clearly influenced by socio-individual factors related to the patient. These factors can play an important role in identifying the etiopathogenesis of the underlying cardiopulmonary disease causing dyspnea. The main goal of rehabilitation is to improve dyspnea; hence, quantifying dyspnea through specific tools (scales) is essential in order to describe the level of chronic disability and to assess eventual changes after intervention. Improvements, even if modest, are likely to determine clinically relevant changes (minimal clinically important difference, MCID) in patients.Currently there exist a large number of scales to classify and characterize dyspnea: the most frequently used in everyday clinical practice are the clinical scales (e.g. MRC or BDI/TDI, in which information is obtained directly from the patients through interview) and psychophysical scales (such as the Borg scale or VAS, which assess symptom intensity in response to a specific stimulus, e.g. exercise).It is also possible to assess the individual's dyspnea in relation to specific situations, e.g. chronic dyspnea (with scales that classify patients according to different levels of respiratory disability); exertional dyspnea (with tools that can measure the level of dyspnea in response to a physical stimulus); and transitional (or 'follow up') dyspnea (with scales that measure the effect in time of a treatment intervention, such as rehabilitation).

Figures

Figure 1
Figure 1
Dyspnea Measurement Tools and Relative Changes (Post-Rehabilitation) According to the MCID. Definition of abbreviations: MCID, minimal clinically important difference; MRC, Medical Research Council; TDI, Transitional Dyspnea Index; VAS, Visual Analogue Scale.
Figure 2
Figure 2
Visual Analogue Scale (VAS). From [44], mod.

References

    1. American Thoracic Society. Dyspnea. Mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med. 1999;159:321–340.
    1. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais F, Morgan M, O'Donnell D, Prefault C, Reardon J, Rochester C, Schols A, Singh S, Troosters T. ATS/ERS Pulmonary Rehabilitation Writing Committee. American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation. Am J Respir Crit Care Med. 2006;173:1390–1413. doi: 10.1164/rccm.200508-1211ST.
    1. Jones PW, Wilson RC. In: Respiratory sensations. Adams L, Guz A, editor. New York: Marcel Dekker; 1996. Cognitive aspects of breathlessness; pp. 311–339.
    1. Simon PM, Schwartzstein RM, Weiss JW, Fencl V, Teghtsoonian M, Weinberger SE. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis. 1990;142:1009–1014.
    1. Elliott MW, Adams L, Cockcroft A, Macrae KD, Murphy K, Guz A. The language of breathlessness. Use of verbal descriptors by patients with cardiopulmonary disease. Am Rev Respir Dis. 1991;144:826–832. doi: 10.1164/ajrccm/144.4.826.
    1. Mahler DA, Harver A, Lentine T, Scott JA, Beck K, Schwartzstein RM. Descriptors of breathlessness in cardiorespiratory diseases. Am J Respir Crit Care Med. 1996;154:1357–1363.
    1. Williams M, Cafarella P, Olds T, Petkov J, Frith P. The language of breathlessness differentiates between patients with COPD and age-matched adults. Chest. 2008;134:489–496. doi: 10.1378/chest.07-2916.
    1. Paintal AS. Vagal sensory receptors and their reflex effects. Physiol Rev. 1973;53:159–227.
    1. Taguchi O, Kikuchi Y, Hida W, Iwase N, Satoh M, Chonan T, Takishima T. Effects of bronchoconstriction and external resistive loading on the sensation of dyspnea. J Appl Physiol. 1991;71:2183–2190.
    1. Mc Closkey DI. In: The nervous system. Handbook of physiology. Brookhart JM, Mouncastle VB, editor. Vol. 2. Bethesda: American Physiological Society; 1981. Corollary discharges: motor commands and perception; pp. 1415–1447.
    1. Killian KJ, Campbell EJ. In: The Thorax, Part B. Roussos C, editor. New York: Marcel Dekker; 1995. Dyspnea; pp. 1709–1747.
    1. O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:770–777.
    1. O'Donnell DE, Bertley JC, Chau LK, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med. 1997;155:109–115.
    1. O'Donnell DE, Chau LK, Webb KA. Qualitative aspects of exertional dyspnea in patients with interstitial lung disease. J Appl Physiol. 1998;84:2000–2009.
    1. O'Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Respir Dis. 1993;148:1351–1357.
    1. Scano G, Stendardi L, Grazzini M. Understanding dyspnoea by its language. Eur Respir J. 2005;25:380–385. doi: 10.1183/09031936.05.00059404.
    1. Banzett RB, Lansing RW, Reid MB, Adams L, Brown R. "Air hunger" arising from increased PCO2 in mechanically ventilated quadriplegics. Respir Physiol. 1989;76:53–67. doi: 10.1016/0034-5687(89)90017-0.
    1. Chida M, Inase N, Ichioka M, Miyazato I, Marumo F. Ratings of perceived exertion in chronic obstructive pulmonary disease: a possible indicator for exercise training in patients with this disease. Eur J Appl Physiol Occup Physiol. 1991;62:390–393. doi: 10.1007/BF00626608.
    1. Mahler DA, Ward J, Mejia-Alfaro R. Stability of dyspnea ratings after exercise training in patients with COPD. Med Sci Sports Exerc. 2003;35:1083–1087. doi: 10.1249/.
    1. Mahler DA, Harver A. A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992;145:467–470.
    1. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
    1. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J. 1959;2:257–266. doi: 10.1136/bmj.2.5147.257.
    1. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581–586. doi: 10.1136/thx.54.7.581.
    1. de Torres JP, Pinto-Plata V, Ingenito E, Bagley P, Gray A, Berger R, Celli B. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest. 2002;121:1092–1098. doi: 10.1378/chest.121.4.1092.
    1. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984;85:751–758. doi: 10.1378/chest.85.6.751.
    1. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42:773–778. doi: 10.1136/thx.42.10.773.
    1. Mahler DA, Ward J, Fierro-Carrion G, Waterman L, Lentine TF, Mejia-Alfaro R, Baird JC. Development of self-administered versions of modified baseline and transition dyspnea indexes in COPD. COPD. 2004;1:165–172. doi: 10.1081/COPD-120030829.
    1. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93:580–586. doi: 10.1378/chest.93.3.580.
    1. Guyatt GH, Thompson PJ, Berman LB, Sullivan MJ, Townsend M, Jones NL, Pugsley SO. How should we measure function in patients with chronic heart and lung disease? J Chronic Dis. 1985;38:517–524. doi: 10.1016/0021-9681(85)90035-9.
    1. Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax. 2003;58:399–404. doi: 10.1136/thorax.58.5.399.
    1. Mahler DA, Tomlinson D, Olmstead EM, Tosteson AN, O'Connor GT. Changes in dyspnea, health status, and lung function in chronic airway disease. Am J Respir Crit Care Med. 1995;151:61–65.
    1. Witek TJ Jr, Mahler DA. Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J. 2003;21:267–272. doi: 10.1183/09031936.03.00068503a.
    1. Mahler DA, Witek TJ Jr. The MCID of the transition dyspnea index is a total score of one unit. COPD. 2005;2:99–103. doi: 10.1081/COPD-200050666.
    1. Stevens SS. On the psychophysical law. Psychol Rev. 1957;64:153–181.
    1. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med. 1970;2:92–98.
    1. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377–381.
    1. Mahler DA, Horowitz MB. Perception of breathlessness during exercise in patients with respiratory disease. Med Sci Sports Exerc. 1994;26:1078–1081.
    1. Mador MJ, Rodis A, Magalang UJ. Reproducibility of Borg scale measurements of dyspnea during exercise in patients with COPD. Chest. 1995;107:1590–1597. doi: 10.1378/chest.107.6.1590.
    1. Stulbarg MS, Carrieri-Kohlman V, Demir-Deviren S, Nguyen HQ, Adams L, Tsang AH, Duda J, Gold WM, Paul S. Exercise training improves outcomes of a dyspnea self-management program. J Cardiopulm Rehab. 2002;22:109–121. doi: 10.1097/00008483-200203000-00010.
    1. Foglio K, Bianchi L, Bruletti G, Battista L, Pagani M, Ambrosino N. Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. Eur Respir J. 1999;13:125–132. doi: 10.1183/09031936.99.13112599.
    1. Eaton T, Garrett JE, Young P, Fergusson W, Kolbe J, Rudkin S, Whyte K. Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. Eur Respir J. 2002;20:306–312. doi: 10.1183/09031936.02.00301002.
    1. Martinez FJ, de Oca MM, Whyte RI, Stetz J, Gay SE, Celli BR. Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med. 1997;155:1984–1990.
    1. Ries AL. Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD. 2005;2:105–110. doi: 10.1081/COPD-200050655.
    1. Aitken RC. Measurement of feelings using visual analogue scales. Proc R Soc Med. 1969;62:989–993.
    1. Reardon J, Awad E, Normandin E, Vale F, Clark B, ZuWallack RL. The effect of comprehensive outpatient pulmonary rehabilitation on dyspnea. Chest. 1994;105:1046–1052. doi: 10.1378/chest.105.4.1046.
    1. Horne D, Corsello P. Physical and occupational therapy for patients with chronic lung disease. Semin Respir Med. 1993;14:466–481. doi: 10.1055/s-2007-1006342.
    1. Garrod R, Bestall JC, Paul EA, Wedzicha JA, Jones PW. Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL) Respir Med. 2000;94:589–596. doi: 10.1053/rmed.2000.0786.
    1. Lareau SC, Carrieri-Kohlman V, Janson-Bjerklie S, Roos PJ. Development and testing of the Pulmonary Functional Status and Dyspnea Questionnaire (PFSDQ) Heart Lung. 1994;23:242–250.
    1. McGavin CR, Artvinli M, Naoe H, McHardy GJ. Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. Br Med J. 1978;2:241–243. doi: 10.1136/bmj.2.6132.241.
    1. Garrod R, Paul EA, Wedzicha JA. An evaluation of the reliability and sensitivity of the London Chest Activity of Daily Living Scale (LCADL) Respir Med. 2002;96:725–730. doi: 10.1053/rmed.2002.1338.
    1. Costi S, Crisafulli E, Antoni FD, Beneventi C, Fabbri LM, Clini EM. Effects of unsupported upper extremity exercise training in patients with COPD: a randomized clinical trial. Chest. 2009;136:387–395. doi: 10.1378/chest.09-0165.
    1. Lareau SC, Meek PM, Roos PJ. Development and testing of the modified version of the pulmonary functional status and dyspnea questionnaire (PFSDQ-M) Heart Lung. 1998;27:159–168. doi: 10.1016/S0147-9563(98)90003-6.
    1. O'Brien B, Viramontes JL. Willingness to pay: a valid and reliable measure of health state preference? Med Decis Making. 1994;14:289–297. doi: 10.1177/0272989X9401400311.
    1. Janssens JP, Breitenstein E, Rochat T, Fitting JW. Does the 'oxygen cost diagram' reflect changes in six minute walking distance in follow up studies? Respir Med. 1999;93:810–815. doi: 10.1016/S0954-6111(99)90266-4.
    1. Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol. 1999;52:187–192. doi: 10.1016/S0895-4356(98)00157-7.
    1. Velloso M, Stella SG, Cendon S, Silva AC, Jardim JR. Metabolic and ventilatory parameters of four activities of daily living accomplished with arms in COPD patients. Chest. 2003;123:1047–1053. doi: 10.1378/chest.123.4.1047.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться